Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Salmonella enterica serovar Typhi H58, an antimicrobial-resistant lineage, is globally disseminated but has not been reported in Latin America. Genomic analysis revealed 3 independent introductions of Salmonella Typhi H58 with reduced fluoroquinolone susceptibility into Chile. Our findings highlight the utility of enhanced genomic surveillance for typhoid fever in this region.

More information Original publication

DOI

10.3201/eid2611.201676

Type

Journal article

Publication Date

2020-11-01T00:00:00+00:00

Volume

26

Pages

2736 - 2740

Total pages

4

Keywords

Humans, Salmonella typhi, Typhoid Fever, Fluoroquinolones, Anti-Bacterial Agents, Microbial Sensitivity Tests, Drug Resistance, Bacterial, Chile